O'Day Daniel Patrick at Gilead Sciences, Inc. (GILD) Sells 15,881 Shares
O'Day Daniel Patrick, of Gilead Sciences, Inc. (NASDAQ:GILD), sold 15,881 shares of company stock on October 30, 2026, according to a Form 4 filing with the Securities and…
Gilead Sciences, Inc. (NASDAQ:GILD) · insider sell
Insider
O'Day Daniel Patrick
Transaction
insider sell
Shares
15,881
Price per share
$175.25
Total value
$2.8M
Shares owned after
566,683
At a glance
Key takeaways
01Gilead Sciences executive O'Day Daniel Patrick sold 15,881 shares at $175.25 per share on October 30, 2026, totaling $2.8 million.
02Following the sale, O'Day retained 566,683 shares of Gilead stock, indicating continued significant personal investment in the company.
03Gilead Sciences currently trades at $167.47 with a market capitalization of $152.9 billion.
04Multiple insider sales by the same executive occurred on November 2, 2026, involving approximately 15,000 additional shares across five separate transactions.
Transaction Details
O'Day Daniel Patrick, of Gilead Sciences, Inc. (NASDAQ:GILD), sold 15,881 shares of company stock on October 30, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
The shares were sold at an average price of $175.25 per share, for a total transaction value of $2.8M. Following this transaction, O'Day Daniel Patrick still owns 566,683 shares of Gilead Sciences, Inc. stock.
About Gilead Sciences, Inc.
Gilead Sciences, Inc.'s stock currently trades at $167.47, giving the company a market capitalization of $152.9B.
Insider sales are common and don't necessarily indicate a bearish outlook. Executives regularly sell shares for tax planning, diversification, or personal liquidity. The key factors to watch are the size of the sale relative to the insider's total holdings, whether multiple insiders are selling simultaneously, and whether the trades occur near earnings announcements or other catalysts.
At $2.8 million, this transaction stands out as a significant commitment. Trades of this size from corporate insiders typically attract attention from institutional investors and analysts who track Form 4 filings for early signals about company direction.
Insider transaction data is reported to the SEC via Form 4 filings, typically within two business days of the trade. Investors can track insider activity alongside other metrics — such as institutional flows, short interest, and technical indicators — to build a more complete picture of market sentiment around Gilead Sciences, Inc.
Recent Insider Transactions at Gilead Sciences, Inc.
What does insider insider_sell mean for Gilead Sciences, Inc. stock?
Insider insider_sells at Gilead Sciences, Inc. (NASDAQ:GILD) are reported to the SEC via Form 4 filings. While a single transaction doesn't predict future stock performance, patterns of insider buying can signal management confidence.